Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Meignan

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trialsMichel Meignan, Emmanuel Itti, Stéphane Bardet, et al.
JACC. Cardiovascular Imaging|July 18, 2016
Early Phase <sup>99</sup>Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac AmyloidosisArnault Galat, Axel Van der Gucht, Aziz Guellich, et al.
Blood|March 22, 2018
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL studyAnne Ségolène Cottereau, Annibale Versari, Stefano Luminari, et al.
Hematological Oncology|May 23, 2022
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic studyRexhep Durmo, Benedetta Donati, Louis Rebaud, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 15, 2015
Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosisArnault Galat, Jean Rosso, Aziz Guellich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter StudiesMichel Meignan, Anne Ségolène Cottereau, Annibale Versari, et al.
The Lancet. Oncology|October 13, 2018
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trialJudith Trotman, Sally F Barrington, David Belada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Reply to H.J.A. Adams et al and E. Laffon et alMichel Meignan, Anne Ségolène Cottereau, Annibale Versari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 26, 2015
[18F]-NaF PET/CT imaging in cardiac amyloidosisAxel Van Der Gucht, Arnault Galat, Jean Rosso, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trialsMichel Meignan, Emmanuel Itti, Stéphane Bardet, et al.
JACC. Cardiovascular Imaging|July 18, 2016
Early Phase <sup>99</sup>Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac AmyloidosisArnault Galat, Axel Van der Gucht, Aziz Guellich, et al.
Blood|March 22, 2018
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL studyAnne Ségolène Cottereau, Annibale Versari, Stefano Luminari, et al.
Hematological Oncology|May 23, 2022
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic studyRexhep Durmo, Benedetta Donati, Louis Rebaud, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 15, 2015
Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosisArnault Galat, Jean Rosso, Aziz Guellich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter StudiesMichel Meignan, Anne Ségolène Cottereau, Annibale Versari, et al.
The Lancet. Oncology|October 13, 2018
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trialJudith Trotman, Sally F Barrington, David Belada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Reply to H.J.A. Adams et al and E. Laffon et alMichel Meignan, Anne Ségolène Cottereau, Annibale Versari, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 26, 2015
[18F]-NaF PET/CT imaging in cardiac amyloidosisAxel Van Der Gucht, Arnault Galat, Jean Rosso, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
Pageof 13